HIF1A and cancer: Except for the canonical VHL-mediated rapid proteasomal degradation under normoxia (Cockman et al, 2000), numerous novel regulators of HIF-1α are being identified, particularly in the context of cancer (Amelio et al, 2015; Goto et al, 2015; Kim et al, 2015; Kim et al, 2016).